Krsnaa Diagnostics IPO GMP today:
Krsnaa Diagnostics shares are available at ₹425, ₹45 higher from its yesterday’s grey market premium of ₹380
which is at a premium of around 44.54%
Windlas Biotech IPO GMP today:
Windlas Biotech’s grey market premium remained ₹90
which is at a premium of around 19.56%
Devyani International IPO GMP today:
Devyani International shares are available at ₹63, which is ₹3 higher from its yesterday’s grey market premium of ₹60.
which is at a premium of around 70%
Exxaro Tiles IPO GMP today:
This tile manufacturing company’s shares are available in the grey market at ₹15, which was earlier ₹24 Which is at a premium of around 12.54%
Krsnaa Diagnostics IPO allotment and listing date :
Allotment date: 11-08-2021
Listing date: 17-08-2021
Windlas Biotech IPO allotment and listing date:
Allotment date: 11-08-2021
Listing date: 17-08-2021
Devyani International IPO allotment and listing date:
Allotment date: 11-08-2021
Listing date: 16-08-2021
Exxaro Tiles IPO allotment and listing date:
Allotment date: 11-08-2021
Listing date: 17-08-2021
Krsnaa Diagnostics Profit and loss statement
Krsnaa Diagnostics Total Income
242.41% Upwards , Rs661.48Cr
Krsnaa Diagnostics EBIT ( Earning before interest and taxes)
660.92% Upwards, Rs321.39Cr
Krsnaa Diagnostics PAT ( Profit after tax )
1382.55% Upwards, Rs184.93Cr
Windlas Biotech Profit and loss
Windlas Biotech Total Income
13.60% Upwards, Rs329.84cr
Windlas Biotech EBIT
-14.43% Downwards, Rs32.94cr
Windlas Biotech PAT
-0.06% Downwards, Rs22.46cr
Devyani International profit and loss statement
Devyani International Total Income
-16.29% Downwards, Rs1047.33cr
Devyani International EBIT
-77.73% Downwards, Rs10.76cr
Devyani International Profit after tax
CHECK HERE FOR A FULL ANALYSIS OF DEVYANI INTERNATIONAL
Exxaro Tiles Profit and loss statement
Exxaro Tiles Total Income
6.51% Upwards, Rs251.85cr
Exxaro Tiles EBIT
20.49% Upwards, Rs38.42cr
Exxaro Tiles Profit after tax
35.21% Upwards, Rs15.22cr
1 thought on “Which is best? Devyani International vs Exxaro Tiles IPO vs Krsnaa Diagnostics vs Windlas Biotech”